Skip to main content
Caplight Logo









Biolojic Design

Biolojic Design

Private
IsraelHealthcare & Life Scienceshttps://biolojic.com/

Last Round

Crowdfunding

Jan 1, 2021

Total Funding Raised

$24M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Biolojic Design is a biotechnology company that uses artificial intelligence and computational biology to design and develop programmable antibody therapeutics for autoimmune diseases and immuno-oncology.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

antibody discoverycomputational biologymultibodiesdrug discoveryai drug discoveryin silico drug designprecision medicinebiotechtherapeutic antibodiesprotein engineeringdrug developmentbiologicspharma partnershipsai-native biotechdrug design platform

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Biolojic Design Comparables

Compare Biolojic Design with similar companies based on industry and business-model similarity.

Biolojic Design comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
BigHat Biosciences
83%
AbSci
81%
Nabla Bio
81%

Biolojic Design Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
CrowdfundingJan 1, 2021

Key People

Founding team and executive leadership

Yanay Ofran

Founder & CEO

Founding Team

Micah Pearlman

Chief Operating Officer

Executive Team

Biolojic Design Investors

Notable investors and investment history

Biolojic Design investors
InvestorRounds
aMoonEarly Funding, Crowdfunding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 20, 2026

    Monthly visitors grew 471% MoM, from 423 to 2.4K.

Biolojic Design Filings

Explore SEC and related filing metadata, where available.

Biolojic Design filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Biolojic Design's valuation, stock price, and market status.

Is Biolojic Design a public or private company?

Biolojic Design is a private company.

What is the current stock price of Biolojic Design?

Biolojic Design is a private company with no public stock price. Caplight tracks Biolojic Design's secondary market activity and provides MarketPrice estimates to Caplight users.

How much is Biolojic Design worth (valuation)?

Valuation information for Biolojic Design is not publicly available.

Can I buy Biolojic Design stock?

Biolojic Design shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Biolojic Design's last funding round?

Biolojic Design's most recent funding round was Crowdfunding on January 1, 2021.

Who are the main investors in Biolojic Design?

Key investors in Biolojic Design include aMoon.

Will Biolojic Design IPO soon?

No public IPO plans have been announced for Biolojic Design.

How can I track Biolojic Design secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Biolojic Design's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersIsrael
Employee Range76
Year Founded2009
Last FundingJan 1, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?